RGS4, a GTPase activator, improves renal function in ischemia-reperfusion injury

Kidney International

Volumn 80, Issue 3, 2011, Pages 263-271

  Siedlecki, Andrew M ^a   Jin, Xiaohua ^a   Thomas, Winston ^b   Hruska, Keith A ^a   Muslin, Anthony J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Deltagen   (United States)

Author keywords

acute kidney injury; G protein; ischemia reperfusion; proteasome; RGS

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; ENDOTHELIN 1; RGS4 PROTEIN;

ACUTE KIDNEY TUBULE NECROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; DISEASE MODEL; KIDNEY BLOOD FLOW; KIDNEY CELL; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KNOCKOUT MOUSE; LASER DOPPLER FLOWMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; VASOCONSTRICTION;

EID: 79960415780     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.63     Document Type: Article

References (49)

1. Xue JL, Daniels F, Star RA et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 2006; 17: 1135-1142.
2. Chertow GM, Burdick E, Honour M et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005; 16: 3365-3370. (Pubitemid 46179340)
3. Coca SG, Yusuf B, Shlipak MG et al. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009; 53: 961-973.
4. Schnitzler MA, Hollenbeak C, Cohen DS et al. The economic implications of HLA matching in cadaveric renal transplantation. N Engl J Med 1999; 341: 1440-1446. (Pubitemid 29513461)
5. Cristol JP, Thiemermann C, Mitchell JA et al. Support of renal blood flow after ischaemic-reperfusion injury by endogenous formation of nitric oxide and of cyclo-oxygenase vasodilator metabolites. Br J Pharmacol 1993; 109: 188-194. (Pubitemid 23113821)
6. Shibouta Y, Suzuki N, Shino A et al. Pathophysiological role of endothelin in acute renal failure. Life Sci 1990; 46: 1611-1618. (Pubitemid 20179843)
7. Abels BC, Branch R, Sabra R. Interaction between thromboxane A2 and angiotensin II in postischemic renal vasoconstriction in dogs. J Pharmacol Exp Ther 1993; 264: 1285-1292. (Pubitemid 23318623)
8. Arendshorst WJ, Brannstrom K, Ruan X. Actions of angiotensin II on the renal microvasculature. J Am Soc Nephrol 1999; 10: S149-S161. (Pubitemid 29038180)
9. Naicker S, Bhoola KD. Endothelins: vasoactive modulators of renal function in health and disease. Pharmacol Ther 2001; 90: 61-88. (Pubitemid 32622841)
10. Ergul S, Brunson CY, Hutchinson J et al. Vasoactive factors in sickle cell disease: in vitro evidence for endothelin-1-mediated vasoconstriction. Am J Hematol 2004; 76: 245-251. (Pubitemid 38828844)
11. Abassi ZA, Pieruzzi F, Nakhoul F et al. Effects of cyclosporin A on the synthesis, excretion, and metabolism of endothelin in the rat. Hypertension 1996; 27: 1140-1148. (Pubitemid 26140672)
12. Wilhelm SM, Simonson M, Robinson AV et al. Endothelin up-regulation and localization following renal ischemia and reperfusion. Kidney Int 1999; 55: 1011-1018. (Pubitemid 29100713)
13. Wilhelm SM, Stowe NT, Robinson AV et al. The use of the endothelin receptor antagonist, tezosentan, before or after renal ischemia protects renal function. Transplantation 2001; 27: 211-216. (Pubitemid 32126101)
14. Brunner F, Bras-Silva C, Cerdeira AS et al. Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacol Ther 2006; 111: 508-531. (Pubitemid 43832003)
15. Berman DM, Gilman A. Mammalian RGS proteins: barbarians at the gate. J Biol Chem 1998; 273: 1269-1272. (Pubitemid 28133638)
16. Dohlman HG, Thorner J. RGS proteins and signaling by heterotrimeric G proteins. J Biol Chem 1997; 272: 3871-3874. (Pubitemid 27078439)
17. Druey KM, Blumer K, Kang VH et al. Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family. Nature 1996; 379: 742-746. (Pubitemid 26061739)
18. Watson N, Linder M, Druey KM et al. RGS family members: GTPaseactivating proteins for heterotrimeric G-protein alpha-subunits. Nature 1996; 383: 172-175. (Pubitemid 26303980)
19. Berman DM, Wilkie T, Gilman AG. GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits. Cell 1996; 86: 445-452. (Pubitemid 26272084)
20. Hepler JR, Berman DM, Gilman AG et al. RGS4 and GAIP are GTPase-activating proteins for Gq alpha and block activation of phospholipase C beta by gamma-thio-GTP-Gq alpha. Proc Natl Acad Sci USA 1997; 94: 428-432.
21. Tesmer JJ, Berman DM, Gilman AG et al. Structure of RGS4 bound to AlF4-activated G(i alpha1): stabilization of the transition state for GTP hydrolysis. Cell 1997; 89: 251-261. (Pubitemid 27199897)
22. Huang C, Hepler JR, Gilman AG et al. Attenuation of Gi-and Gq-mediated signaling by expression of RGS4 or GAIP in mammalian cells. Proc Natl Acad Sci USA 1997; 94: 6159-6163.
23. Kwon YT, Kashina AS, Davydov IV et al. An essential role of N-terminal arginylation in cardiovascular development. Science 2002; 297: 96-99. (Pubitemid 34743100)
24. Bodenstein J, Sunahara R, Neubig RR. N-terminal residues control proteasomal degradation of RGS2, RGS4, and RGS5 in human embryonic kidney 293 cells. Mol Pharmacol 2007; 71: 1040-1050. (Pubitemid 46457008)
25. Gu S, Cifelli C, Wang S et al. RGS proteins: identifying new GAPs in the understanding of blood pressure regulation and cardiovascular function. Clin Sci 2009; 116: 391-399.
26. Berman DM, Wilkie T, Gilman AG. GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits. Cell 1996; 86: 445-452. (Pubitemid 26272084)
27. Rogers JH, Tsirka A, Kovacs A et al. RGS4 reduces contractile dysfunction and hypertrophic gene induction in Galpha q overexpressing mice. J Mol Cell Cardiol 2001; 33: 209-218. (Pubitemid 32537921)
28. Siedlecki A, Anderson J, Jin X et al. RGS4 controls renal blood flow and inhibits cyclosporine-mediated nephrotoxicity. Am J Transplant 2010; 10: 231-241.
29. Gobé G, Zhang XJ, Willgoss DA et al. Relationship between expression of Bcl-2 genes and growth factors in ischemic acute renal failure in the rat. J Am Soc Nephrol 2000; 11: 454-467. (Pubitemid 30115075)
30. Chiao H, Kohda Y, McLeroy P et al. Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest 1997; 99: 1165-1172. (Pubitemid 27142751)
31. Albig AR, Schiemann W. Identification and characterization of regulator of G protein signaling 4 (RGS4) as a novel inhibitor of tubulogenesis: RGS4 inhibits mitogen-activated protein kinases and vascular endothelial growth factor signaling. Mol Biol Cell 2005; 16: 609-625. (Pubitemid 40165559)
32. Saito M, Miyagawa I. Real-time monitoring of nitric oxide in ischemiareperfusion rat kidney. Urol Res 2000; 28: 141-146. (Pubitemid 30397419)
33. Gross V, Lippoldt A, Luft FC. Pressure diuresis and natriuresis in DOCA-salt mice. Kidney Int 1997; 52: 1364-1368. (Pubitemid 27496066)
34. Shi H, Patschan D, Epstein T et al. Delayed recovery of renal regional blood flow in diabetic mice subjected to acute ischemic kidney injury. Am J Physiol Renal Physiol 2007; 293: F1512-F1517. (Pubitemid 350085986)
35. Romero DG, Zhou M, Yanes LL et al. Regulators of G-protein signaling 4 in adrenal gland: localization, regulation, and role in aldosterone secretion. J Endocrinol 2007; 194: 429-440. (Pubitemid 47249679)
36. Ebert PJ, Campbell DB, Levitt P. Bacterial artificial chromosome transgenic analysis of dynamic expression patterns of regulator of G-protein signaling 4 during development. I. Cerebral cortex. Neuroscience 2006; 142: 1145-1161. (Pubitemid 44642333)
37. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med 1996; 334: 1448-1460. (Pubitemid 126590563)
38. Pappachan JV, Millar B, Bennett ED et al. Comparison of outcome from intensive care admission after adjustment for case mix by the APACHE III prognostic system. Chest 1999; 115: 802-810. (Pubitemid 29129964)
39. Clermont G, Acker CG, Angus DC et al. Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int 2002; 62: 986-996. (Pubitemid 35316729)
40. Smits JM, van Houwelingen H, De Meester J et al. Permanent detrimental effect of nonimmunological factors on long-term renal graft survival: a parsimonious model of time-dependency. Transplantation 2000; 70: 317-323. (Pubitemid 30602751)
41. Hu W, Li F, Mahavadi S et al. Upregulation of RGS4 expression by IL-1beta in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3beta pathway. Am J Physiol Cell Physiol 2009; 296: C1310-C1320.
42. Hu W, Li F, Mahavadi S et al. Interleukin-1beta up-regulates RGS4 through the canonical IKK2/IkappaBalpha/NF-kappaB pathway in rabbit colonic smooth muscle. Biochem J 2008; 412: 35-43.
43. Hu RG, Sheng J, Qi X et al. The N-end rule pathway as a nitric oxide sensor controlling the levels of multiple regulators. Nature 2005; 437: 981-986. (Pubitemid 41486974)
44. Sriram SM, Banerjee R, Kane RS et al. Multivalency-assisted control of intracellular signaling pathways: application for ubiquitin-dependent N-end rule pathway. Chem Biol 2009; 16: 121-131.
45. Heximer SP, Knutsen R, Sun X et al. Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J Clin Invest 2003; 111: 445-452. (Pubitemid 36228001)
46. Takimoto E, Koitabashi N, Hsu S et al. Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice. J Clin Invest 2009; 119: 408-420.
47. Hu Y, Smith DE, Ma K et al. Targeted disruption of peptide transporter Pept1 gene in mice significantly reduces dipeptide absorption in intestine. Mol Pharm 2008; 5: 1122-1130.
48. Stegbauer J, Vonend O, Habbel S et al. Angiotensin II modulates renal sympathetic neurotransmission through nitric oxide in AT2 receptor knockout mice. J Hypertens 2005; 23: 1691-1698. (Pubitemid 41233429)
49. Bredt DS, Mourey RJ, Snyder SH. A simple, sensitive, and specific radioreceptor assay for inositol 1,4,5-trisphosphate in biological tissues. Biochem Biophys Res Commun 1989; 159: 976-982. (Pubitemid 19101078)